China SXT Pharmaceuticals
SXTC
SXTC
2 hedge funds and large institutions have $35.5K invested in China SXT Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Holders
2
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$23.5K | |
| 2 | -$6.15K | |
| 3 | -$5.26K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$5.22K |
| 5 |
HF
HRT Financial
New York
|
-$5K |